Log in

2257 Sirnaomics Ltd. HKEX · Hong Kong

Sirnaomics (2257) news

Sirnaomics Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2257, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sirnaomics news

We have not published a story on Sirnaomics yet. When there is news, it will appear here.

Questions about Sirnaomics

What is the ticker symbol of Sirnaomics?

Sirnaomics Ltd. trades under the ticker 2257 on HKEX.

Where is Sirnaomics listed?

Sirnaomics Ltd. is listed on HKEX.

Which country or territory is Sirnaomics listed under?

Our directory records Sirnaomics Ltd. under Hong Kong.

What does Sirnaomics do?

Our directory classifies Sirnaomics Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Sirnaomics?

The ISIN recorded for Sirnaomics Ltd. is KYG2050P1028.

Does aibio.space cover Sirnaomics?

aibio.space lists Sirnaomics Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Sirnaomics?

Companies in our directory listed in the same country and business area as Sirnaomics: Genscript Biotech, CPBIO Holding Company, SinoMab Bioscience, China NT Pharma Group Co., China Regenerative Medicine International, Beijing Tong Ren Tang Chinese Medicine Co..

Investor discussion: Sirnaomics

Members talk about Sirnaomics (2257). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Sirnaomics, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND GRANT OF REPURCHASE RIGHT. Source

  2. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND GRANT OF REPURCHASE RIGHT. Source

  3. Financings

    Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  4. Financings

    Share or debt issue: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  5. Financings

    Share or debt issue: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING. Source

  6. Financings

    Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  7. Financings

    Share or debt issue: PARTIAL COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND TERMINATION OF SUBSCRIPTION AGREEMENT. Source

  8. Financings

    Share or debt issue: PARTIAL COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND TERMINATION OF SUBSCRIPTION AGREEMENT. Source

  9. Financings

    Share or debt issue: SUPPLEMENTAL ANNOUNCEMENT SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  10. Financings

    Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. Source

  11. Financings

    Share or debt issue: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING. Source

  12. Mergers

    Transaction under the Listing Rules: MAJOR TRANSACTION AND GRANT OF DRAG-ALONG RIGHT AND NOTICE OF EXTRAORDINARY GENERAL MEETING. Source

  13. Mergers

    Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF CIRCULAR. Source

  14. Mergers

    Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF CIRCULAR. Source

Press releases

Headlines of Sirnaomics's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    DISCLOSEABLE TRANSACTION SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND GRANT OF REPURCHASE RIGHT

  2. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

  3. HKEXnews

    DISCLOSEABLE TRANSACTION - DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND GRANT OF REPURCHASE RIGHT

  4. HKEXnews

    INSIDE INFORMATION - ISSUE OF A WRIT OF SUMMONS

  5. HKEXnews

    COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE

  6. HKEXnews

    VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT DOSING IN THE PHASE II CLINICAL TRIAL OF STP705 FOR MEDICAL AESTHETIC

  7. HKEXnews

    VOLUNTARY ANNOUNCEMENT - ESTABLISHMENT OF EXTERNAL SCIENTIFIC ADVISORY BOARD

  8. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, JUNE 30, 2026

  9. HKEXnews

    VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY A DIRECTOR

  10. HKEXnews

    SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  11. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 23, 2026 AND AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION

  12. HKEXnews

    DOCUMENTS ON DISPLAY

  13. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  14. HKEXnews

    1. PROPOSED TERMINATION OF THE 2022 RSU SCHEME AND PROPOSED ADOPTION OF THE 2026 RSU SCHEME AND 2. PROPOSED TERMINATION OF THE 2022 SHARE OPTION SCHEME AND PROPOSED ADOPTION OF THE 2026 SHARE OPTION SCHEME 3. NOTICE OF EGM

  15. HKEXnews

    BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING

  16. HKEXnews

    RESIGNATION OF NON-EXECUTIVE DIRECTOR, WITHDRAWAL OF RESOLUTION AT THE ANNUAL GENERAL MEETING AND CHANGES IN COMPOSITION OF BOARD COMMITTEES

  17. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE

  18. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  19. HKEXnews

    PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

  20. HKEXnews

    SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2257 on TradingView.

Listing details

Sirnaomics Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2257, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Sirnaomics Ltd.
Ticker
2257
Listing
HKEX
Country or territory
Hong Kong
Business scope
Biotechnology
ISIN
KYG2050P1028
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.